Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010 - Watch the "What This Means" video ...

OpenAI claims the full GPT-4.1 model outperforms its GPT-4o and GPT-4o mini models on coding benchmarks, including SWE-bench.

PRINCETON, N.J., March 26, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings ... safety review of the expansion cohort in its Phase 1 SB101 clinical trial evaluating SON-1010, the Company ...

Continuing its almost 30-year legacy of Mac expansion, Sonnet's new Thunderbolt 5 hardware transforms Apple's Mac mini into a rack-mounted workstation with high-speed PCI-e. Sonnet Technologies is ...

Sonnet BioTherapeutics (SONN) announced positive findings from the first safety review of the expansion cohort in its Phase 1 SB101 clinical trial evaluating SON-1010, the Company’s proprietary ...